Cargando…
NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer’s, and Ethanol Intoxication
Glutamate carboxypeptidase II (GCPII) inactivates the peptide neurotransmitter N-acetylaspartylglutamate (NAAG) following synaptic release. Inhibitors of GCPII increase extracellular NAAG levels and are efficacious in animal models of clinical disorders via NAAG activation of a group II metabotropic...
Autores principales: | Olszewski, Rafal T., Janczura, Karolina J., Bzdega, Tomasz, Der, Elise K., Venzor, Faustino, O’Rourke, Brennen, Hark, Timothy J., Craddock, Kirsten E., Balasubramanian, Shankar, Moussa, Charbel, Neale, Joseph H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603630/ https://www.ncbi.nlm.nih.gov/pubmed/28285415 http://dx.doi.org/10.1007/s11064-017-2181-4 |
Ejemplares similares
-
NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia
por: Olszewski, R T, et al.
Publicado: (2012) -
NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation
por: Yamada, Toshihiko, et al.
Publicado: (2012) -
The regulatory role of NAAG-mGluR3 signaling on cortical synaptic plasticity after hypoxic ischemia
por: Li, Kexin, et al.
Publicado: (2022) -
Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain
por: Yamamoto, Tatsuo, et al.
Publicado: (2008) -
Group I mGluRs in Therapy and Diagnosis of Parkinson’s Disease: Focus on mGluR5 Subtype
por: Azam, Shofiul, et al.
Publicado: (2022)